Yes, please see the links about the BLA getting an RTF, the PR about Mahboob leaving, and the several CC's where Nader changed the reason for the RTF several times over the course of some months. See the PR's about their 'very successful' meeting the FDA about the BLA that had no followup. See their PR's about meetings with Canada and the UK about the BLA that had no follow up. See the expected submission date for the BLA start in 2019 and continue to as of now the end of 2021. With OTC stocks you need to do a bit of legwork putting the pieces together. Shams like Nader will never feed you the information, they will give you hints and pieces, it is critical that an OTC investor be wise to see past the BS to the real picture. I fear you are unable to do that. That's unfortunately because to a well trained eye such as mine the situation is crystal clear. Listening to my expert opinion would serve you well. But it's up to you.
News 
Market Data 
Discover 
